Article
GMP Production and Scale-Up of Adherent Neural Stem Cells with a Quantum Cell Expansion System
7 Jul 2018
Abstract excerpt
Cell-based therapies hold great promise for a myriad of clinical applications. However, as these therapies move from phase I to phase II and III trials, there is a need to improve scale-up of adherent cells for the production of larger good manufacturing practice (GMP) cell banks. As we advanced our neural stem cell (NSC)-mediated gene therapy trials for glioma to include dose escalation and multiple treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
